Heather Raymon

Heather Raymon, Ph.D., has 25 years of biotech and biopharma industry experience. She was most recently Executive Director, Early Development Program Leadership at Celgene/Bristol Myers Squibb where she was leading multiple clinical stage programs in immuno-oncology and neuroscience. Prior to that, Heather was Sr. Director and Head of Pharmacology at Celgene where she built a department that was responsible for developing pharmacology data packages in support of regulatory filings in oncology and inflammation/immunology. Heather started her biotech career at Signal Pharmaceuticals working in neurobiology and cellular and molecular pharmacology before the company was acquired by Celgene. Heather received her BS in Biology from SUNY Albany, a PhD in Pharmacology and Toxicology at University of California, Irvine, and was a postdoctoral fellow at Salk Institute for Biological Studies and University of California, San Diego.